evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract
17815,GENE_BACKGROUND,,"KMT2D encodes the histone methyltransferase MLL2, an epigenetic modulator that methylates lysine residue 4 on the tail of histone H3 (H3K4). Methylation of H3K4 leads to increased genome accessibility, recruitment of transcriptional complexes, and activation of gene expression (PMID: 25998713). Deletion of MLL2 in human cells leads to genomic instability due to transcriptional stress (PMID: 26883360). In murine models, loss of MLL2 results in accelerated B cell malignancy, impaired B cell differentiation, and defects in class switching (PMID: 26366710). MLL2 activity is critical for the survival and proliferation of MLL1-rearranged leukemias (PMID: 28609655). Though MLL2 is not as commonly mutated as MLL1 in human cancers, MLL2 is one of the most recurrently mutated genes in follicular and diffuse large B cell lymphoma (PMID: 24476821, 21804550, 21796119, 24476821).",,2017-10-04,,8085,KMT2D,0001-01-03,False,ENST00000301067,NM_003482.3,AAD10,KABUK1,MLL2,TNRC21,ALR,CAGL114,True,24476821,Comprehensive molecular characterization of urothelial bladder carcinoma.,Nature,2018-03-20T20:14:00,507,7492,315-22,Cancer Genome Atlas Research Network.,doi: 10.1038/nature12965,,0001-03-20,,21804550,Analysis of the coding genome of diffuse large B-cell lymphoma.,Nature genetics,2018-07-31T20:11:00,43,9,830-7,Pasqualucci L et al,doi: 10.1038/ng.892,,0001-07-31,,26883360,Mutation of cancer driver MLL2 results in transcription stress and genome instability.,Genes &amp; development,2018-02-15T20:16:00,30,4,408-20,Kantidakis T et al,doi: 10.1101/gad.275453.115,,0001-02-15,,26366710,The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.,Nature medicine,2018-10-01T20:15:00,21,10,1199-208,Ortega-Molina A et al,doi: 10.1038/nm.3943,,2018-10-01T02:08:00,,21796119,Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.,Nature,2018-07-27T20:11:00,476,7360,298-303,Morin RD et al,doi: 10.1038/nature10351,,2018-07-27T03:03:00,,28609655,"MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.",Cancer cell,2018-06-12T20:17:00,31,6,755-770.e6,Chen Y et al,doi: 10.1016/j.ccell.2017.05.002,,0001-06-12,,25998713,Hijacked in cancer: the KMT2 (MLL) family of methyltransferases.,Nature reviews. Cancer,2018-06-01T20:15:00,15,6,334-46,Rao RC et al,doi: 10.1038/nrc3929,,0001-06-01,
17814,GENE_SUMMARY,,KMT2D encodes a tumor suppressor and histone methyltransferase involved in regulating gene expression. KMT2D is one of the most frequently mutated genes across all cancer types.,,2017-04-27,,8085,KMT2D,0001-01-03,False,ENST00000301067,NM_003482.3,AAD10,KABUK1,MLL2,TNRC21,ALR,CAGL114,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
